Dashboard
Analysis
Charting
Screener
Resources
Settings
NYSE-MA
Mar '15
Dec '16
Sep '18
Jun '20
Mar '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
568.8
561.9
548.1
526.6
493.8
441.2
Total Shares Outstanding
900
906
909.8
913.4
919.7
925.6
Market Cap
511,929
509,117.6
498,679.6
480,969
454,147.9
408,337.7
Total Enterprise Value (TEV)
520,279
518,741.6
509,612.6
490,453
461,162.9
416,645.7
Dividend Yield
0.1%
0.2%
Buyback Yield
2.2%
2.3%
2%
Debt Paydown Yield
—
-0.9%
-0.5%
-0.2%
Shareholder Yield
1.2%
1.4%
1.7%
1.8%
P/S
16.3
16.8
17.2
17.1
16.7
15.5
P/Gross Profit
P/E
36.4
37.9
38.4
37.4
33.7
Earnings Yield
2.7%
2.6%
3%
P/OCF
29.3
30
32.2
32.5
32.3
33.5
P/FCF
30.1
30.8
33.2
33.6
33.3
34.8
FCF Yield
3.3%
2.9%
P/B
64.8
74.8
74.2
61
55
EV/Sales
16.5
17.5
17.4
16.9
15.8
EV/Gross Profit
EV/EBITDA
24.7
26.1
26.9
26.8
24
EV/EBIT
29
31.6
31.5
30.7
28
EV/OCF
29.8
30.6
32.9
32.8
34.2
EV/FCF
31.3
33.9
34.3
35.5
Dividends
DPS
0.8
0.7
Payout Ratio
17.5%
18.7%
21.2%
18.1%
18.9%
Margins
Gross Profit Margin
100%
Operating Margin
58.8%
58.7%
57.2%
52.6%
54.3%
58%
EBITDA Margin
68.4%
68.5%
67.6%
62.4%
64.2%
67.2%
Net Profit Margin
45.7%
45.5%
45.2%
44.6%
44.3%
46.8%
Effective Tax Rate
21.4%
20.8%
18.6%
14.1%
15.6%
17.3%
Pre-Tax Profit Margin
58.1%
57.4%
55.6%
52%
52.5%
56.6%
Free Cash Flow Margin
63.8%
56.1%
30.6%
63.3%
68.2%
43.4%
OCF / Sales
65.8%
32.8%
64.5%
69.7%
45.1%
OCF / Net Income
144.2%
124.4%
72.6%
144.6%
157.4%
96.3%
FCF / OCF
96.9%
99.1%
93.3%
98%
97.9%
FCF / Net Income
139.7%
123.3%
67.7%
141.8%
154.1%
92.8%
FCF / EBITDA
93.2%
81.8%
45.3%
101.5%
106.3%
64.6%
Capital Efficiency
Return on Invested Capital
11.6%
11.3%
10.1%
10.4%
Return on Assets
7.9%
8.1%
7.4%
7.5%
7.8%
8.2%
Return on Equity
50.9%
48.2%
49.5%
47%
49.9%
Return on Total Capital
21.3%
21.8%
19.6%
19.9%
19.8%
Return on Capital Employed
16.2%
14.7%
14.3%
14.5%
15.8%
Return on Tangible Assets
10.7%
11.1%
10.2%
10.3%
11.2%
Receivables Turnover
1.4
1.3
1.2
Days Sales Outstanding
256.3
276.3
301.1
265.3
273.3
284.5
Asset Turnover
0.2
Fixed Asset Turnover
3.8
3.7
3.4
3.6
CapEx to OCF
0
0.1
CapEx to Revenue
CapEx to Depreciation
Financial Health
Total Debt
18,983
18,970
18,802
18,226
18,358
15,605
Net Debt
8,335
9,603
10,908
9,454
6,957
8,247
Current Ratio
1.1
1
Quick Ratio
Cash Ratio
0.5
0.4
Debt Ratio
Assets to Equity
6.7
6.5
7.2
7.4
6.3
5.7
Cash Flow to Debt Ratio
0.3
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-22,162
-21,438
-21,995
-21,872
-17,497
-17,132
Goodwill / Assets
Debt / Equity
2.4
2.8
2.1
Total Debt / Capitalization
Long Term Debt / Capitalization
0.9
Long-Term Debt / Equity
2.7
2.3
1.9
Net Debt / EBITDA
1.7
2.2
2
1.5
1.8
EBIT / Interest Expense
27.2
24.5
22.8
21.4
25.2
26.4
EBITDA / Interest Expense
28.6
25.4
(EBITDA - Capex) / Interest Expense
28.4
26
24.9
29.1
Per Share
Revenue per Share
9.5
8.9
7.9
8.1
8
7.5
Basic EPS
4.4
4.1
3.5
Diluted EPS
4.3
Book Value per Share
8.7
8.6
7.3
7.1
Tangible Book Value per Share
-8
-8.1
-9
-8.9
-4.9
-4.6
Cash per Share
11.8
10.3
12.3
Operating Cash Flow per Share
5.1
2.6
5.3
5.6
Free Cash Flow per Share
6.1
5
5.2
5.4
3.3
CapEx per Share
Weighted Avg. Shares Outstanding
903
908
912
917
923
929
Weighted Avg. Shares Outstanding Diluted
905
909
914
919
925
930
Common Size
SG&A to Revenue
36.8%
36.6%
36.9%
40.6%
40.2%
37.4%
Stock-based Comp to Revenue
2.1%
